A ‘breadth of protection:’ Novavax’s newly-approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant

by | Jul 14, 2022 | Uncategorized

Novavax says its vaccine prompted ‘broad immune responses’ against all COVID variants, including BA.5, in clinical data. Read More